Warfield, Kelly L.
Schaaf, Kaitlyn R.
DeWald, Lisa Evans
Spurgers, Kevin B.
Wang, Wei
Stavale, Eric
Mendenhall, Michelle
Shilts, Meghan H.
Stockwell, Timothy B. http://orcid.org/0000-0002-3595-4539
Barnard, Dale L. http://orcid.org/0000-0002-4505-020X
Ramstedt, Urban
Das, Suman R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201100030C, U19AI110819, P30 AI110527, U19AI095227)
Article History
Received: 7 January 2019
Accepted: 8 April 2019
First Online: 16 May 2019
Competing Interests
: W.W., E.S., M.M., K.R.S., M.H.S., T.B.S. and D.L.B. declare no competing interests. K.L.W., L.E.D. and K.B.S. are employees and shareholders of Emergent BioSolutions. K.L.W. and U.R. are authors on pending and issued patents related to the use of iminosugars as treatments for viral disease. S.R.D. has been funded by Emergent BioSolutions. Other authors have no competing financial and/or non-financial interests.